Cook Steven L. 4/A
Research Summary
AI-generated summary
Omada Health (OMDA) CFO Steven Cook Exercises Options & Sells Shares
What Happened
Steven L. Cook, Chief Financial Officer of Omada Health (OMDA), exercised a total of 2,900 option shares (2,600 on 6/24/2026 and 300 on 6/25/2026) at a $8.01 strike (total exercise cost reported $23,229) and sold those shares the same days for aggregate proceeds of approximately $55,146. The sales were reported as open-market disposals (weighted-average prices reported of ~$19.02 and $19.00). The filing is an amendment to the original Form 4 to add the omitted exercise entries; the corresponding sales were timely reported in the original filing.
Key Details
- Dates & prices:
- 2026-06-24: exercised 2,600 shares @ $8.01 (reported $20,826) and sold 2,600 shares @ $19.02 (reported $49,445; executed in multiple trades; weighted avg per F3/F4).
- 2026-06-25: exercised 300 shares @ $8.01 (reported $2,403) and sold 300 shares @ $19.00 (reported $5,701).
- Total: 2,900 options exercised for ~$23,229; total sale proceeds reported ~$55,146.
- Post-transaction holdings: the amended Form 4 states Box 5 (beneficial ownership) was adjusted to correct an understatement due to the omitted exercises — see the Form 4/A for the exact post-transaction figure.
- Footnotes: filing is an amendment to correct omitted exercise transactions (F1); the sale(s) were made pursuant to a 10b5-1 trading plan adopted March 14, 2026 (F2); sale executions were in multiple trades with weighted-average prices (F3/F4); option vesting is monthly from Feb 1, 2024, fully vested after four years (F5).
- Timeliness: the original Form 4 reported the sales timely; this Form 4/A restates the filing to add the previously omitted exercises.
Context
These were same-day exercise-and-sale transactions (often called cashless exercises): Cook exercised vested options and immediately sold the shares. Such transactions are typically routine liquidity events rather than direct endorsements of company prospects. The amendment simply corrects reporting to show the exercises that produced the sold shares; it does not change the fact that sales were previously disclosed.